One Target - Two Different Binding Modes: Structural Insights into Gevokizumab and Canakinumab Interactions to Interleukin-1βMichaela Blech, Herbert Nar, Peter Fischer et al.|DORA PSI (Paul Scherrer Institute)|2013Cited by 0